Browse Category

Stock Market 29 March 2026 - 30 March 2026

Lululemon Shares Jump 8% with Overseas Expansion Balancing Lower U.S. Sales
Intel Corporation’s 18A Bet Faces First Market Test as Business PCs Arrive Tuesday

Intel Corporation’s 18A Bet Faces First Market Test as Business PCs Arrive Tuesday

Intel Corporation’s initial commercial PCs featuring its 18A process are slated to land with customers Tuesday, Dell among the earliest to deliver systems. The chipmaker said PCs using its Core Ultra Series 3 and vPro platform—covering management and security—will hit the market starting March 31. Dell has its Pro 14 Premium, Pro 5 Micro, and Pro Precision 7 lined up for release that same day.
CrowdStrike Stock Rises After Wolfe Upgrade as Anthropic AI Fears Turn Into Cybersecurity Spending Bet

CrowdStrike Stock Rises After Wolfe Upgrade as Anthropic AI Fears Turn Into Cybersecurity Spending Bet

CrowdStrike stock climbed roughly 3% in premarket trade this Monday, after Wolfe Research bumped its rating up to Outperform from Peer Perform. The firm pointed to Anthropic’s anticipated rollout of a more advanced AI model, saying it could drive increased security budgets rather than threaten cybersecurity providers. Wolfe assigned a price target of $450.
Nvidia Stock Hits 7-Year Valuation Low Even as New AI Orders Roll In

Nvidia Stock Hits 7-Year Valuation Low Even as New AI Orders Roll In

Nvidia Corp’s forward price-to-earnings ratio has slumped to its lowest point since early 2019—a striking reversal for the chipmaker that has become the face of Wall Street’s AI enthusiasm. Shares sit nearly 20% off the October record, and right now, the stock is trading at about 19.6 times projected 12-month earnings. That’s just under the S&P 500’s multiple, which hovers near 20. The gap stands out, considering analysts expect Nvidia’s profits to jump more than 70% this fiscal year. For the S&P 500, that number is closer to 19%.
Stock Market Crash Fears Rise as Oil, Bond Yields and Volatility Hit Wall Street at Once

Stock Market Crash Fears Rise as Oil, Bond Yields and Volatility Hit Wall Street at Once

Crash chatter has only picked up as Wall Street gears up for Monday's open, with Friday’s sharp drop dragging both the Dow and Nasdaq into correction territory—each now off at least 10% from their recent peaks. The S&P 500 sits just a shade above that threshold, down a little over 1% away. U.S. stock futures ticked a bit higher early Monday, but after five consecutive weeks in the red, it hardly looked like anyone was breathing easy just yet.
30 March 2026
Indian Stocks Log Worst Month Since 2020 as Sensex, Nifty Tumble and Rupee Breaches 95

Indian Stocks Log Worst Month Since 2020 as Sensex, Nifty Tumble and Rupee Breaches 95

Indian equities wrapped up their bleakest month since March 2020 on Monday. The Sensex slid 2.22% to settle at 71,947.55, while the Nifty 50 retreated 2.14% to 22,331.4 as crude surged above $115 a barrel amid the escalating Middle East conflict. That finish pushed the Sensex to depths not seen in over two years. The rupee crossed 95 against the dollar for the first time, marking a third consecutive day of historic lows.
30 March 2026
US Stock Market Today: Live Updates 30.03.2026

US Stock Market Today: Live Updates 30.03.2026

LIVEMarkets rolling coverageStarted: March 30, 2026, 12:00 AM EDTUpdated: March 30, 2026, 11:59 PM EDT Bombardier Share Price Volatility Sparks Valuation Debate Amid Divergent Market Signals March 30, 2026, 11:45 PM EDT. Bombardier (TSX:BBD.B) shares dropped 2.2% in one day and 17.7% over a month, stirring investor attention. Despite recent declines, the company has posted a robust 186.6% total return over one year and impressive five-year gains. The stock trades at CA$232.07, about 53% above its intrinsic value estimate of CA$47.40, raising questions about overvaluation. There's a stark contrast in valuation views: a narrative tags Bombardier as overvalued by nearly
30 March 2026
US Stock Market Today: Live Updates 29.03.2026

US Stock Market Today: Live Updates 29.03.2026

LIVEMarkets rolling coverageStarted: March 29, 2026, 12:00 AM EDTUpdated: March 29, 2026, 11:59 PM EDT Kailera Biotech Plans IPO for Phase 3 Obesity Drug from Hengrui March 29, 2026, 11:59 PM EDT. Kailera Biotech, a well-funded biotech startup, is preparing for an initial public offering (IPO) as it advances its obesity drug candidate to Phase 3 trials. The move aims to enter a competitive market currently dominated by established players like Eli Lilly and Novo Nordisk. The company hopes the IPO will support continued development and commercialization efforts amid rising demand for effective obesity treatments. Undervalued Pet Sector Stock Rises
29 March 2026
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Constellation Energy

NASDAQ: CEG 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY

Walt Disney

NYSE: DIS 92 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 90 / 100
#5 BUY ON PULLBACK

Cheniere Energy

NYSE: LNG 88 / 100
View full portfolio
Editorial model selection. Not personalised advice.